$OCGN
Ocugen, Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Malvern, PA
OCGN chart
What traders are saying about $OCGN
Latest postsOcugen, Inc. news
- Is Ocugen (NASDAQ:OCGN) Starting a Pivotal Eye Study?
Kalkine Media ·
- Ocugen Secures Gene Therapy Licenses Ahead of Phase 3 Results
MyChesCo ·
- Ocugen Licenses OCU400 Rights in Australia, New Zealand, ASEAN to Celairis
Minichart ·
- Form 8K Ocugen, Inc For: 10 November By Investing.com
Investing.com India ·
- A 50% gross-profit share is part of Ocugen (OCGN)'s eight-country OCU400 license deal.
Stock Titan ·
- Ocugen licenses gene therapy OCU400 to Celairis for Asia-Pacific By Investing.com
Investing.com India ·
- Ocugen and Celairis Therapeutics Enter into Exclusive License Agreement for OCU400 in Australia, New Zealand, and ASEAN
Yahoo Finance ·
- A deal for an experimental vision-loss treatment spans a region home to about 725 million people
Stock Titan ·
- symbol__ Stock Quote Price and Forecast
CNN ·
- Lobbying Update: $30,000 of OCUGEN INC. lobbying was just disclosed
Quiver Quantitative ·
- Ocugen Inc. stock rises Monday, outperforms market
MarketWatch ·
- Ocugen's Q3 Earnings Match Estimates, Revenues Beat, Stock Rises
Yahoo Finance ·
Ocugen, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $4.4M | $4.1M | $6.0M | $2.5M |
| Net income | -$68.0M | -$54.0M | -$63.0M | -$86.8M |
| Diluted EPS | – | – | $-0.26 | $-0.40 |
| Total assets (year end) | $43.5M | $82.4M | $64.5M | $108.6M |
| Cash and equivalents (year end) | $18.6M | – | $39.5M | $77.6M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Ocugen, Inc.
- Ticker
- OCGN (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Malvern, PA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1372299
- Former names
- HISTOGENICS CORP
Frequently asked questions
What exchange is Ocugen, Inc. listed on?
Ocugen, Inc. trades on the Nasdaq under the ticker symbol OCGN.
What industry is Ocugen, Inc. in?
Ocugen, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Ocugen, Inc. headquartered?
Ocugen, Inc.'s business address on file with the SEC is in Malvern, PA.
When does Ocugen, Inc.'s fiscal year end?
Ocugen, Inc.'s fiscal year ends on December 31.
How much revenue did Ocugen, Inc. report?
Ocugen, Inc. reported $4.4M in revenue for calendar year 2025, according to its SEC filings.